ArticleJournal of vascular surgery cases and innovative techniques2026
Distal revascularization and interval ligation for femoral arteriovenous graft steal syndrome.
Article in Journal of vascular surgery cases and innovative techniques, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Patients with end-stage renal disease and exhausted upper extremity options may require lower extremity arteriovenous grafts (AVGs) for hemodialysis access. We present a 62-year-old woman with a right superficial femoral artery-femoral vein looped AVG who developed limb-threatening ischemia secondary to steal syndrome. A distal revascularization and interval ligation procedure, using an external iliac-to-distal superficial femoral artery bypass with interval ligation, successfully restored perfusion while preserving access. The patient's ischemic symptoms resolved, and both AVG and bypass remained patent at >2 years, demonstrating distal revascularization and interval ligation as an effective limb-salvaging option.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.